A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period
Clinical trial NCT03414736 · COMPLETED
Trial details
- NCT number
- NCT03414736
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-19
- Primary completion
- 2018-10-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.